Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
-
TD Cowen Reiterates Buy Rating on AstraZeneca (AZN)
-
TD Cowen Reiterates Buy Rating on AstraZeneca (AZN)
-
AstraZeneca (AZN) PT Raised to $95 at TD Cowen
-
TD Cowen Reiterates Buy Rating on AstraZeneca (AZN)
-
TD Cowen Reiterates Buy Rating on AstraZeneca (AZN)
-
Newly Released FDA Briefing Docs Add Uncertainty Over Fibrogen's (FGEN) Roxadustat Approval
-
What to Expect Ahead of AstraZeneca's (AZN) Roxadustat FDA Adcom on July 15?
-
Cowen Out Positive on AstraZeneca (AZN)
-
AstraZeneca (AZN) Cited as Top Pharma Idea at Cowen
-
U.S. drugmaker earnings heat up this week with spotlight on vaccine news
-
AstraZeneca (AZN) PT Raised to $60 at Cowen
-
Moderna to Present at Upcoming Investor Conferences
-
AstraZeneca (AZN) PT Raised to $55 at Cowen; 'Best Idea for 2020'
-
Cowen Upgrades AstraZeneca (AZN) to Outperform
-
AstraZeneca (AZN): Notes From Management Dinner - Cowen
-
Bristol-Myers lung cancer delay slams shares, keeps Merck in lead
-
Streetinsider.com's Hot Lunchtime Reads 10/4: (DPS) (SNI) (CRTO) (SNY)
-
Streetinsider.com's Hot Lunchtime Reads 12/11: (F) (AZN) (IMOS) (FNSR)
-
Notable Analyst Rating Changes 7/2: (T) (KOS) (KIM) Upgraded; (GNRC) (BTU) (RF) Downgraded
-
Notable Analyst Rating Changes 1/16: (TUBE) (NFLX) (APC) Upgraded; (AYR) (RGC) (GPS) Downgraded
-
MELA Sciences (MELA) Makes Several Key Board Appointees
-
Cowen & Co Downgrades AstraZeneca (AZN) to Neutral
-
Notable Analyst Rating Changes 10/29: BIIB, MTH, PCU Upgraded; JNJ, SWIR, ULTI Downgraded
-
Cowen & Co Initiates Coverage on AstraZeneca (AZN) with an Outperform

